Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) will report its Q2 2026 financial results after market close on Aug. 6, 2026, and hold a conference call at 4:30 p.m. ET to discuss results and business updates, according to the company. The release also describes its iMRI platforms TULSA-PRO and Sonalleve and related regulatory clearances.
How this was made
The 30-second read
Why it matters
The primary tradable element is the scheduled Q2 2026 results release after the close on Aug. 6, followed by a 4:30 p.m. ET conference call.
Market read
This is a forward-looking earnings-event scheduling update that can inform options and pre-earnings positioning, but it contains no financial metrics or guidance.
What to watch
Volatility may be driven more by any subsequent 8-K/press release details (revenue, margins, procedure volumes, guidance) than by the scheduled call time, which is not itself predictive.
Background
Profound is a commercial-stage medical device company focused on interventional MRI procedures (TULSA-PRO and Sonalleve).
Ticker impact
Profound Medical will release Q2 2026 financial results after the close on Aug. 6 and hold a 4:30 p.m. ET conference call.
Likely modest pre-event positioning and post-release volatility; direction depends on Q2 results and guidance, which are not provided here.
The article discloses only the timing of the upcoming results and call, with no numbers, guidance, or operational updates.
Market effects
Could increase near-term attention on commercial-stage interventional MRI device names ahead of results season, but no sector datapoints are disclosed.
Limited, since the disclosure is company-specific and not tied to a macro/regional policy change.
Low, despite mentioning global clearances, because no new regulatory or commercial expansion facts are provided.
Counterpoint
Because the release date is already the main disclosed item, traders may treat this as largely priced-in and focus on what management says on the call rather than the calendar itself.
Key entities
- companyProfound Medical Corp.
NASDAQ-listed medical device company announcing its Q2 2026 results date and conference call details.
